Harry, with Commander Kenneth Mackenzie Grieve R.N
To be clear, GLP-1s are not FDA-approved for treating these conditions right now, but if more research proves they are safe and effective, they could receive formal approval for these uses (or others) in the future
When discussing weight loss medicines, it is helpful to ask your GP or specialist about: Currently licensed and NICE-approved options available to you on the NHS or privately Eligibility criteria for specific treatments and what monitoring would be required Realistic expectations regarding weight loss outcomes, timescales, and the importance of lifestyle changes alongside medication Potential side effects , including gastrointestinal symptoms commonly associated with GLP-1 receptor agonists, and how these are managed If you experience any suspected side effects from a weight management medicine, you can report these directly to the MHRA via the Yellow Card Scheme (available at yellowcard.mhra.gov.uk)
Is it safe to delay my tirzepatide dose by a few days
La FDA ha identificado precauciones importantes, incluyendo el riesgo de pancreatitis aguda, enfermedad de la vescula biliar y posibles efectos sobre la tiroides